Abstract
Hepatocellular carcinoma (HCC) is a frequent and deadly human disease (1). Several lines of evidence indicate that the gradual accumulation of genomic alterations, leading to progressive deregulation of different signaling pathways, induces the progressive evolution of initiated liver cells to dysplastic nodules and malignant lesions (1). Molecular events leading to cell cycle deregulation in HCC include up-regulation of RAS/ERK, PI3K/AKT, IKK/NF-kB, WNT, TGF-β, NOTCH, HEDGEHOG, and HIPPO signaling pathways, and genes involved in DNA repair process (2). Better understanding of the molecular mechanisms underlying hepatocarcinogenesis may hasten the identification of novel molecular HCC progression markers and development of new diagnostic and therapeutic strategies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
